Turn Therapeutics Inc.
TTRX
$3.98
$0.102.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -80.63% | -103.82% | -58.56% | -10.78% | 22.86% |
| Total Depreciation and Amortization | 11.37% | 17.74% | 25.00% | 16.03% | 7.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -594.63% | 66.47% | 10,592.19% | 62.78% | -43.60% |
| Change in Net Operating Assets | 124,652.63% | 497.80% | -21.07% | -56.00% | -100.83% |
| Cash from Operations | -88.25% | -40.14% | -24.79% | -11.36% | 1.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -53.77% | -20.82% | -5.19% | -48.21% | -125.11% |
| Cash from Investing | -53.77% | -20.82% | -5.19% | -48.21% | -125.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 500.39% | 576.50% | 1,201.47% | 537.75% | 130.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 500.39% | 576.50% | 1,201.47% | 537.75% | 130.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,463.04% | 399.68% | 317.82% | 200.83% | 66.55% |